Markets, deals, earnings and the briefings that matter to readers in India.
Business
Experts argue that Trump's upcoming 100% tariff on pharmaceuticals will primarily hurt the US, not India. The move is expected to escalate medication costs in America while India continues to provide…
The Indian equity market faced a significant downturn this week, largely due to newly imposed US tariffs on pharmaceuticals. With…
India's aviation sector shows resilience with a year-on-year rise in domestic passenger traffic by 0.3% in August. Analysts…
In an enlightening address, Dr. Jitendra Singh reveals how technology sovereignty is set to redefine geopolitical power dynamics.…
As festive fervor grips the nation, consumer sales have leaped by 23–25% within just two days of Navratri, thanks to new GST…
Discover how the Employees’ State Insurance Corporation (ESIC) has added over 20.36 lakh new employees in July, with a…
The GST Council's upcoming meeting may prove pivotal as it aims to address the inverted duty structure affecting notebooks and…
Mumbai and Pune are experiencing an unprecedented surge in housing sales post-COVID, with combined sales nearly doubling to over…
In a bold legal move, Elon Musk's AI startup xAI has taken OpenAI to court, alleging the theft of trade secrets. This dispute…
